LB Pharmaceuticals Inc (LBRX) › Weighted Average Diluted SharesLB Pharmaceuticals Inc (LBRX): Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.8.05MYear ended 2025-12-312024-12-31: 358.2K2025-12-31: 8.05M8.05M2024-12-31 Weighted Average Diluted Shares (shares) 2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-318.05Mn/m2026-03-26, From 2025-01-012024-12-31358.2Kn/a2026-03-26, From 2024-01-01Other metrics: R&D ExpenseDepreciation & AmortizationNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShares OutstandingEPS (Basic)